Pharmaceutical Supply Chains - Medicines Shortages
This book provides an insight of relevant case studies and updated practices in “PharmaceuticalSupply Chains” (PharmSC) while addressing the most relevant topics within the COST Action “Medicines Shortages” (CA15105).The volume focuses on the most recent
- PDF / 6,081,178 Bytes
- 268 Pages / 453.544 x 683.151 pts Page_size
- 33 Downloads / 229 Views
Ana Paula Barbosa-Povoa Helena Jenzer João Luís de Miranda Editors
Pharmaceutical Supply Chains— Medicines Shortages
Lecture Notes in Logistics Series Editors Uwe Clausen, Flow and Logistics IML, Fraunhofer Institute for Material, Dortmund, Germany Michael ten Hompel, Flow and Logistics IML, Fraunhofer Institute for Material, Dortmund, Germany Robert de Souza, The Logistics Institute—Asia Pacific, National University of Singapore, Singapore, Singapore
More information about this series at http://www.springer.com/series/11220
Ana Paula Barbosa-Povoa Helena Jenzer João Luís de Miranda •
•
Editors
Pharmaceutical Supply Chains—Medicines Shortages
123
Editors Ana Paula Barbosa-Povoa Department of Engineering and Management Instituto Superior Técnico Lisboa, Portugal
Helena Jenzer aF&E Ernährung und Diätetik Berner Fachhochschule Bern, Switzerland
João Luís de Miranda ESTG/IPP Portalegre, Portugal CERENA/Instituto Superior Técnico Lisboa, Portugal
ISSN 2194-8917 ISSN 2194-8925 (electronic) Lecture Notes in Logistics ISBN 978-3-030-15397-7 ISBN 978-3-030-15398-4 (eBook) https://doi.org/10.1007/978-3-030-15398-4 Library of Congress Control Number: 2019934366 © Springer Nature Switzerland AG 2019 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, expressed or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This Springer imprint is published by the registered company Springer Nature Switzerland AG The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland
Support
v
vi
Support
Foreword
“Medicines shortages.” Two words representing a severe problem across the globe, even in the most developed healthcare systems and top-quality industry. Something that one would not expect in the twenty-first century, when we see an accelerating development of modern technologies, modern medicine (and the science of drug development) being closer and closer to the molecular essence of diseases, giving birth to neolo
Data Loading...
